CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for CathRx Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

CathRx Limited
5 Parkview Drive, Homebush Bay
Phone: +61 293975700p:+61 293975700 Eveleigh, NSW  2127  Australia Ticker: CXD CXD

This company is no longer actively traded on any major stock exchange.

Business Summary
CathRx Limited is an Australian-based company principally engaged in the research, development and commercialization of a range of catheter devices for the re-processable devices market. During the fiscal year ended June 30, 2011, the Company focused on a technology deal in relation to its re-processable catheter platform. The cardiac catheters are designed to maximize re-manufacturability. In March 2011, the Company received European Conformity (CE) Marking for the first generation irrigated ablation catheter coupled with its patented variable deflectable stylet. The irrigated ablation catheter is the first catheter in the Company’s therapeutic catheter range, which is designed for use in the treatment of cardiac arrhythmias. In August 2011, the Company announced that it had entered into term sheets with two prospective licensees for the development and commercialization of cardiac catheters in Europe.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20126/30/2012Yes----

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board, Chief Executive Officer Denis M.Hanley 65 2/2/2012 4/3/2003
President GerardWallace 6/17/2008 6/17/2008
Chief Financial Officer AmandaWong 9/28/2009 9/28/2009
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 62 (As of 6/30/2008)
Outstanding Shares: 163,748,745 (As of 9/18/2012)
Shareholders: 654
Stock Exchange: ASX
Fax Number: +61 293975701


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023